Phlegmasia Cerulea Dolens (PCD) as a Complication of Covi-19: Case Report
Introduction:
Phlegmasia Cerulea Dolens (PCD) is a rare condition with high mortality and
morbidity risk resulting due to massive deep venous thrombosis (DVT), arterial
occlusion and subsequent compartment syndrome[1-2]. These patients are seen to
present with a classical triad of severe pain, significant edema and bluish
discoloration (cyanosis) of the affected limb[3].
PCD is the only accepted indication for thrombolysis and/or thrombectomy in
patients with DVT, especially in those with signs of ischemia or gangrene.
Accordingly, catheter – directed thrombolysis or urgent removal of the
occluding thrombi using manual techniques (surgical or catheter-directed
thrombectomy) should be seriously considered in this population of patients[4].
The management of this rare condition, its early recognition and initiation of
prompt empiric treatment to prevent the lethal complications is vital.
Treatment options include, anticoagulation, systemic thrombolytics, catheter
directed thrombolysis (CDT), pharmacomechanical CDT, surgical and percutaneous
thrombectomy[5]. We report a 42-year-old male, post COVID-19 (2 months),
presenting with PCD and treated with thrombectomy.
Case Report:
A 42-year-old male presented to the out-patient department of our tertiary care
hospital with complains of swelling and discoloration of his left lower limb
(LLL), on/off pain in the limb and cough. The cough was gradual in onset,
present for the past 2 months, non-productive and associated with fever
initially (not anymore). He also gave history of one episode of hemoptysis in
the past 2 days. Two months ago the patient was in his usual health and had
symptoms of cough and body aches. He was diagnosed as a case of COVID-19 and
supportively managed. After two weeks, he developed Deep Venous Thrombosis
(DVT) and was started on anticoagulation. The patient had no history of
thrombotic events or thrombolysis. The DVT progressed in the next fortnight and
the patient’s LLL swelling worsened.
Upon examination, the patient was not sitting comfortably in his bed with a
mild cough and left lower extremity pain. Vitally stable. Systemic examination
was unremarkable. Lower left limb examination revealed (Figure 1 and 2) grossly
edematous limb, gangrenous with necrotic skin patches, purple in color, cold up
to the knee, pulses were palpable in the femoral region while doppler signals
were very weak below the popliteal artery, weak motor response and intact
sensory responses. The right lower limb was normal.
An urgent CT-angiogram was performed (Video 1) which showed left Dorsalis pedis
and Posterior tibial arteries not opacified with contrast. Diffuse subcutaneous
and deep soft tissue edema. Left femoral, tibial and saphenous veins are distended
(possibly DVT). Another significant finding from the CTA was the evidence of
pulmonary embolism with evolving pulmonary infarcts bilaterally, multiple mixed
cavitating and non-cavitating lesions in both lungs associated with ground
glass haze and small left pleural effusion, multiple large mediastinal and
upper abdominal lymph nodes, hilar lymph nodes eroding walls of bilateral
pulmonary arteries.
Left inguinal incision was given and femoral vein exposed. Proximal and distal
control attained, and vein opened. A large clot was visualized with no venous
flow (Figure 3). Thrombectomy was done using suction and fogarty (Video 2).
Also, distal compression of leg was done to mobilize the thrombus. Both
proximal and distal veins approached. Free venous flow was established. Veins
closed with 6/0 prolene.
The patient was kept on anticoagulation post operatively and mobilized on the
1st post-op day. Significant improvements in the sign and symptoms of left leg
were seen post operatively and he was subsequently discharged to home.
Discussion:
Phlegmasia Cerulea Dolens (PCD) is an emergency and prompt actions are
necessary for limb salvage. It has various risk factors, such as malignancy,
heparin induced thrombocytopenia, femoral vein catheterization, anti-phospholipid
antibody syndrome, and pregnancy, all these lead to hypercoagulable state[6].
The SARS-CoV-2 (COVID-19) is a respiratory syndrome associated with a
hypercoagulable state in adult and hence a potential risk factor for DVT[7].
DVT complicating to PCD have been reported in cases of HIV-AIDS, COVID-19 and
cancer patients[7-9].
It is a rare complication but can occur at all ages with no gender predominance
of note as of now. However, the involvement of left-sided limbs in comparison
to the right have been established. This is due to the compression of left
common iliac vein by right common iliac artery[6]. The pathogenesis of PCD
involves the complete obstruction of the superficial and deep venous return,
resulting in increased interstitial tissue pressure, arrest of capillary flow,
tissue ischemia and eventually gangrene of the limb[10].
Diagnosis of PCD is mainly clinical. The use of Doppler Ultrasound and Computed
Tomography also has a role in ascertaining the diagnosis[11]. Once the
diagnosis is established, I/V Heparin should be initiated and thrombus removal
plan discussed and conducted[12]. Two options for thrombus removals exist,
venous thrombectomy or endovascular methods that include catheter directed or
pharmacomechanical thrombectomy. The mode of treatment will largely depend on
the condition of the patient determined by the clinical categories of Acute
Limb Ischemia (ALI)[13]. In this patient, the surgical thrombectomy option was
opted for as the limb ischemia was increasing and immediate action was required
to save the limb. In addition, the patient was unstable hematologically with an
INR of 6.46 and APTT varying between 60 and 90 seconds, yet the patient’s
condition was not improving. Post-operative examination of the left lower limb
had shown significant improvement however, the swelling and discoloration had
not subsided completely.
Conclusion:
PCD is a possible complication of COVID-19 and it can effectively be treated
with open thrombectomy.
